Nevro Corp. (NYSE: NVRO)
Health Care · Health Care Equipment & Supplies · US
$—
— today · — 1Y
Nevro Corp. (NYSE: NVRO) operates in the Health Care Equipment & Supplies industry within the Health Care sector.
Tweenvest scores Nevro Corp. across four factors: quality 53/100, growth 46/100. Its strongest factor is quality.
NVRO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $408.52M
- P/E
- —
- EPS
- -3.06
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 1,099
- Next earnings
- —
About Nevro Corp.
Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
- ISIN
- US64157F1030
- Founded
- 2006
- Listed since
- Nov 6, 2014
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.78 | -0.02% |
| Stryker CorporationNYSE: SYK | $126.81B | $331.82 | +0.37% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.15 | +0.63% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $48.57 | -2.59% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.